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Background: Observational studies have documented an under-treatment of women in the setting of NSTE-ACS in clinical practice. Little is known 
about gender differences in adjunctive treatment and outcome of patients undergoing PCI for NSTE-ACS in Europe.
Methods: From July 2005 to April 2008, 47,409 consecutive patients undergoing PCI were enrolled into the ongoing PCI-Registry of the Euro 
Heart Survey Programme (99 centres in 30 ESC-countries) to document patient characteristics, procedural details and hospital complications. 
We examined the impact of female gender on adjunctive medical treatment and on hospital outcome of PCI in 13,526 patients with NSTE-ACS in 
clinical practice in Europe.
Results: Female patients (27.5%) were about 7 years older than males, more often had concomitant diseases and less often 3-vessel-disease as 
compared to male patients. Adjunctive medical treatment was similar in women and men. Univariate analysis revealed a higher rate of in-hospital 
death, MI and stroke for women. However, after correction for differences in baseline characteristics and the marked difference in age, female 
gender did not influence hospital mortality of NSTE-ACS undergoing PCI in clinical practice (OR 1.27, 95% CI 0.87-1.87).
Conclusion: Women with NSTE-ACS undergoing PCI in Europe were at mean 7 years older than men. Adjunctive medical treatment did not differ 
between women and men in the setting of PCI. Female gender did not impact on hospital outcome of PCI in NSTE-ACS in clinical practice. 
Female Gender
n=3,717
Male Gender
n=9,809
p-value
Age [years] 71 64 < 0.01
Prior MI 29.5 % 32.4 % <0.01
Prior PCI 20.9 % 23.2 % =0.05
Diabetes mellitus 34.5 % 24.0 % <0.01
3-Vessel Disease 24.4 % 26.8 % <0.05
GP IIb/IIIa 22.3 % 23.5 % Ns
ASA 91.8 % 91.4 % Ns
Clopidogrel 81.3 % 80.4 % Ns
LMW-Heparin 37.2 % 35.2 % <0.05
Hospital Mortality 1.7 % 0.9 % <0.01
Death / MI / Stroke 4.3 % 2.5 % <0.01
